Suppliers · Producer
Daiichi Sankyo
Daiichi Sankyo positions itself as a leader in the development of Antibody Drug Conjugates (ADCs) through its proprietary DXd ADC technology.
Profile
- Industry
- Pharma & biologics
- Topics
- Role
- Producer — “…Daiichi Sankyo positions itself as a leader in the development of Antibody Drug Conjugates (ADCs) through its proprietary DXd ADC technology.…”
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
Status
Seen at forums
- Events
- Asia Bio Partnering Forum CHINABIO
- Years
- 2024–2027
Listed in the programme or participant lists of these events; this is not an endorsement or a ranking. Data sources and method →
Network: owners, partners, peers
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member